Austar Lifesciences Limited announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 517.985 million compared to CNY 477.786 million a year ago. Operating income was CNY 12.066 million compared to CNY 1.341 million a year ago. Net income was CNY 12.782 million compared to CNY 4.169 million a year ago. Basic earnings per share was CNY 0.02 compared to CNY 0.01 a year ago.